Public-registry site landscape for NCT05730218, a Rhegmatogenous Retinal Detachment - Macula Off study sponsored by ONL Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05730218 (registry record) |
| Sponsor | ONL Therapeutics |
| Condition(s) | Rhegmatogenous Retinal Detachment - Macula Off |
| Phase | PHASE2 |
| Listed sites | 36 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05730218 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →